Tirzepatide Reconstitution & Storage — Research Guide

Tirzepatide is a dual GIP / GLP-1 receptor agonist with a fatty-acid side chain extending half-life to ~5 days supplied as a lyophilized powder for laboratory research. Correct reconstitution and storage are the single biggest determinants of measured potency, peak concentration, and inter-experiment reproducibility when working with dual incretin analogues. This guide compiles the reconstitution ratios, diluent choices, concentration tables, storage temperatures, and stability windows most commonly cited in the published research literature.

Reconstitution Reference

| Vial Size | BAC Water Added | Working Concentration | Vol for 2.5 mg | Vol for 5 mg | Vol for 15 mg | | --- | --- | --- | --- | --- | --- | | 5 mg | 1.0 mL | 5.0 mg/mL | 0.50 mL (50 IU) | 1.00 mL (100 IU) | — | | 5 mg | 2.0 mL | 2.5 mg/mL | 1.00 mL (100 IU) | — | — | | 10 mg | 1.0 mL | 10.0 mg/mL | 0.25 mL (25 IU) | 0.50 mL (50 IU) | — | | 10 mg | 2.0 mL | 5.0 mg/mL | 0.50 mL (50 IU) | 1.00 mL (100 IU) | — | | 15 mg | 1.5 mL | 10.0 mg/mL | 0.25 mL (25 IU) | 0.50 mL (50 IU) | 1.50 mL (150 IU)* | | 30 mg | 3.0 mL | 10.0 mg/mL | 0.25 mL (25 IU) | 0.50 mL (50 IU) | 1.50 mL (150 IU)* |

*A 15 mg dose at 10 mg/mL exceeds a single U-100 syringe and requires two draws or a 1.5 mL syringe.

Titration Concentration Choice

The published tirzepatide research-titration ladder runs 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly:

• 10 mg/mL is the literature-consensus working concentration. Every step from 2.5 mg (25 IU) to 12.5 mg (125 IU, two draws) is readable on standard insulin syringes.
• 5 mg/mL is acceptable for low-dose work (2.5–5 mg) but pushes high-dose draws above 100 IU.
• 2.5 mg/mL is rarely used because high-dose draws exceed 1 mL.

Reconstitution Procedure

1. Equilibrate vials to room temperature.
2. Disinfect rubber stoppers with 70% isopropanol.
3. Add BAC water slowly down the vial wall — never onto the lyophilized cake.
4. Do not shake. Swirl gently if needed. Tirzepatide is a large 39-amino-acid peptide with a C20 fatty-diacid side chain; shear stress is the dominant degradation pathway.
5. Solution should be clear and colorless within 1–3 minutes.

Storage Reference

| State | Temperature | Stability Window | Notes | | --- | --- | --- | --- | | Lyophilized, sealed | 2–8 °C | 24 months (typical COA) | Reference shelf life | | Lyophilized, sealed | –20 °C | 36+ months | Long-term archive | | Reconstituted in BAC | 2–8 °C | 28–56 days | Confirm against batch COA | | Reconstituted, ambient (<25 °C) | Room temperature | Up to 21 days | Reference for analog dual-agonist formulations | | Reconstituted, frozen | –20 °C | Avoid freeze-thaw | Aggregation risk |

Common Reconstitution Errors

• Reconstituting at low concentration. A 30 mg vial at 2.5 mg/mL means 12 mL — well beyond a single vial's headspace. Always confirm vial volume capacity before choosing BAC volume.
• Mixing batches. Never pool reconstituted vials from different lots; concentration and impurity profiles are batch-specific.
• Drawing through the rubber stopper repeatedly. Stopper coring shedding rubber particulate is a documented contamination route after ~20 re-entries.

Concentration Worksheet

Tirzepatide's six-step titration ladder benefits from a per-batch printed dose card recording: lot number, reconstitution date, BAC volume, resulting mg/mL, and each ladder step's mL and IU values.

Frequently Asked Questions

What diluent should be used to reconstitute Tirzepatide? Bacteriostatic water (0.9% benzyl alcohol in sterile water) is the standard diluent across published research protocols. It preserves peptide integrity and inhibits microbial growth, supporting multi-day reuse from a single vial. Sterile water for injection (SWFI) is an acceptable alternative for single-use preparations but offers no antimicrobial protection.

How much bacteriostatic water do I add to a 10 mg vial? Reconstitution volume is a function of the desired working concentration, not a fixed rule. The concentration tables above show 5–10 mg/mL as the most commonly cited working range in the literature. Lower volumes give higher concentration (smaller draw volumes); higher volumes give lower concentration (larger, more accurate draw volumes for low-dose research).

How should the lyophilized powder be stored before reconstitution? Lyophilized Tirzepatide is stored at 2–8 °C in its original sealed vial, protected from light and moisture. For long-term storage beyond the COA's stated shelf life, –20 °C is acceptable for most research peptides. Always allow the vial to reach room temperature before opening to prevent condensation.

How long is reconstituted Tirzepatide stable? Refrigerated stability (2–8 °C) for solutions reconstituted in bacteriostatic water is the figure to use; specific windows are published on each batch's certificate of analysis (COA). General reference ranges from the peptide-stability literature appear in the storage table above. Avoid repeated freeze-thaw cycles, which are the most commonly cited cause of measurable potency loss.

What is the correct technique for adding diluent to the vial? Inject the bacteriostatic water slowly down the inner wall of the vial — never directly onto the lyophilized cake. Allow the powder to dissolve passively; do not shake. Gentle swirling is acceptable if dissolution is slow. Aggressive agitation introduces shear stress that can damage peptide tertiary structure.

How is dose volume calculated from the concentration table? Dose volume (mL) = research dose (mg) ÷ concentration (mg/mL). For insulin syringes marked in units (100 units = 1 mL), multiply the mL value by 100. Worked examples appear in the concentration tables above for the most common Tirzepatide research doses.

Can Tirzepatide be reconstituted in saline or other diluents? Bacteriostatic water remains the published standard. Saline reconstitution is documented in some clinical pharmacology references but is uncommon in independent research settings because it offers no preservative action. Avoid acidic or alkaline buffers unless explicitly required by an assay protocol — pH excursions accelerate peptide degradation.

What if the solution appears cloudy after reconstitution? A cloudy or particulate solution after correct reconstitution indicates either incomplete dissolution, contamination, or peptide aggregation. Do not use cloudy material for research; document the batch and request a replacement vial along with the relevant COA from the supplier.